Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., JacobNara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
The 35th annual Eastern Allergy Conference
Contributions to Conferences: Abstracts
Adverse Outcomes Post-initiation of Systemic Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease: A Long-term Observational UK-based Study
Price, D., Bafadhel, M., Papi, A., Carter, V., Tse, G., Ariti, C., Zhou, J., Skinner, D., Xu, X., Müllerová, H., Emmanuel, B.
Impact of initiating biologics in patients with severe asthma and on long-term oral corticosteroids or rescue steroids (GLITTER)
Chen, W., Tran, T. N., Sadatsafavi, M., Wong, N. C. B., Bulathsinhala, L., Gil, E. G., FitzGerald, J. M., Murray, R. B., Price, D., ISAR GLITTER Working Group
Persistent Reductions in OCS Use in Patients with Severe, OCS-Dependent Asthma Treated with Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Ribas, C. D., Rabe, K., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J., Rowe, P., Deniz, Y., Siddiqui, S.
Predicting Pneumonia events in COPD patients using medical records
Price, D., Henley, W., Carter, V., Skinner, D., Alexander, L., Vella, R., Papi, A., Fabbri, L. M., Kerstjens, H. A., Roche, N., Singh, D., Vogelmeier, C. F., Şen, E., Delfini Cançado, J. E., Kots, M., Nudo, E., Barile, S., Georges, G.
Prevalence of comorbidities in adults with severe asthma: results from the International Severe Asthma Registry (ISAR)
Scelo, G., Porsbjerg, C. M., Carter, V., Ariti, C., Lyu, J., Eleangovan, N., Tran, T. N., Baker, P., Katial, R., Martin, N., Altraja, A., Rhee, C. K., FitzGerald, J. M., Hansen, S., Heaney, L. G., Hew, M., Siyue, M. K., Pfeffer, P. E., Puggioni, F., Tsai, M., von Bülow, A., Eileen, W., Price, D., ISAR PRISM Working Group
Prototype ORACLE Score Validation in NOVELTY: Predicted versus Observed Asthma Exacerbation Rates
Couillard, S., Peterson, S., Bengtsson, T., van den Berge, M., Price, D., Beasley, R., Sadatsafavi, M., Janson, C., Belton, L., Fagerås, M., Müllerová, H., Pavord, I. D.
Relationships Between Symptoms and Lung Function in Asthma and/or Chronic Obstructive Pulmonary Disease in the NOVELTY study
Papi, A., Hughes, R., Olmo, R. d., Agusti, A., Chipps, B. E., Make, B., Tomaszewski, E., Peres Da Costa, K., Srivastava, D., Vestbo, J., Janson, C., Burgel, P., Price, D.
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma
Porsbjerg, C. M., Menzies-Gow, A., Tran, T. N., Murray, R. B., Unni, B., Ang, S. L. A., Alacqua, M., Al-Ahmad, M., Al-Lehebi, R., Altraja, A., Belevskiy, A. S., Björnsdóttir, U. S., Bourdin, A., Busby, J., Walter Canonica, G., Christoff, G., Cosio, B. G., Costello, R. W., FitzGerald, J. M., Fonseca, J. A., Hansen, S., Heaney, L. G., Heffler, E., Hew, M., Iwanaga, T., Jackson, D. J., Kocks, J. W. H., Kallieri, M., Bruce Ko, H., Siyue, M. K., Larenas-Linnemann, D., Lehtimäki, L. A., Loukides, S., Lugogo, N., Maspero, J. F., Papaioannou, A. I., Perez de Llano, L., Márcio Pitrez, P., Popov, T. A., Rasmussen, L. M., Rhee, C. K., Sadatsafavi, M., Schmidt, J., Siddiqui, S., Taillé, C., Taube, C., Torres-Duque, C. A., Ulrik, C., Upham, J. W., Eileen, W., Wechsler, M. E., Bulathsinhala, L., Carter, V., Chaudhry, I., Eleangovan, N., Hosseini, N., Rowlands, M., Price, D., van Boven, J. F.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 10, no. 5
Variation in demographic and clinical characteristics of Patients with COPD receiving care in U.S. primary care: data from the Advancing the Patient EXperience (APEX) in COPD registry
Fox, C., Pace, W. D., Brandt, E., Chang, K., Edwards, C. L., Evans, A., Gaona, G., Han, M. K., Kaplan, A., Kent, R., Kocks, J. W., Kruszyk BEng, M., Le Lievre, C. E., Li Voti, T., Mahle, C., Make, B., Ratigan, A. R., Shaikh, A., Skolnik, N., Stanley, B., Yawn, B. P., Price, D.
Pragmatic and Observational Research, vol. 2022, no. 13, pp. 17-31
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial. (BICS)
Cotton, S., Devereux, G., Abbas, H., Briggs, A. H., Campbell, K., Chaudhuri, R., Choudhury, G., Dawson, D., De Soyza, A., Fielding, S., Gompertz, S., Haughney, J., Lang, C. C., Lee, A., MacLennan, G., MacNee, W., McCormack, K., McMeekin, N., Mills, N. L., Morice, A., Norrie, J., Petrie, L., Price, D., Short, P., Vestbo, J., Walker, P., Wedzicha, J. A., Wilson, A., Lipworth, B. J.
Suboptimal peak inspiratory flow and inhalation technique errors are associated with higher COPD-relateD healthcare costs: results from the PIFotal COPD study
Leving, M., van Boven, J. F., Bosnic-Anticevich, S. Z., van Cooten, J., Correia de Sousa, J., Cvetkosvki, B., Dekhuijzen, P. N. R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Hartgers-Gubbels, L., Janse, Y., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Roman-Rodriguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Kocks, J. W.
IPCRG 2022
Contributions to Conferences: Abstracts
Asthma exacerbation and steroid burden in Australian primary care
Price, D., Hancock, K. L., Bosnic-Anticevich, S., Blakey, J., Hew, M., Chung, L. P., Cvetkovski, B., Claxton, S., Del Fante, P., Denton, E., Doan, J., Ranasinghe, K., Morgan, L., Sharma, A., Smith, P. K., Feldman-Stewart, D., Thompson, P., Wiseman, R., Upham, J. W., Yan, K. Y., Carter, V., Dhillon, K., Heraud, F., Le, T., Vella, R., OPCA Improving Asthma outcomes in Australia Research Group
The Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science 2022, pp. 194
No difference in pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus long-acting bronchodilators
Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kertsjens, H., Roche, N., Singh, D., Vogelmeier, C., Sen, E., Cancado, J., Nudo, E., Barile, S., Georges, G.
Reducción persistente de corticosteroides orales independientemente de la dosis basal, en pacientes con asma córtico-dependiente tratados con dupilumab: Estudio Liberty Asthma-Traverse
Domingo, C., Gurnell, M., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
55 Congreso Separ
Contributions to Conferences: Abstracts
The burden of intermittent oral corticosteroid use in asthma
Heatley, H., Tran, T. N., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Skinner, D., Carter, V., Shi Kai Chan, J., Ariti, C., Haughney, J., Price, D.
IPCRG 2022
Contributions to Conferences: Abstracts
Lower pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone
Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kertsjens, H., Roche, N., Singh, D., Vogelmeier, C., Sen, E., Cancado, J., Nudo, E., Barile, S., Georges, G.
The Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science 2022, pp. 81
CONQUEST: a quality improvement program for defining and optimizing standards of care for modifiable high-risk COPD patients
Alves, L., Pullen, R., Hurst, J. R., Miravitlles, M., Carter, V., Chen, R., Couper, A., Dransfield, M., Evans, A., Hardjojo, A., Jones, D., Jones, R., Kerr, M., Kostikas, K., Marshall, J., Martinez, F. J., van Melle, M., van Melle, M., Murray, R. B., Muro, S., Nordon, C., Pollack, M., Price, C., Sharma, A., Singh, D., Winders, T. A., Price, D.
Patient Related Outcome Measures, vol. 2022, no. 13, pp. 53-68
Interclass difference in pneumonia risk in COPD patients initiating fixed dose inhaled treatment containing extrafine particle beclometasone versus fine particle fluticasone
Price, D., Henley, W., Delfini Cançado, J. E., Fabbri, L. M., Kerstjens, H. A., Papi, A., Roche, N., Şen, E., Singh, D., Vogelmeier, C., Barille, S., Nudo, E., Carter, V., Skinner, D., Vella, R., Georges, G.
International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 355—370
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., JacobNara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Aspen Allergy Conference – 40th Meeting
Contributions to Conferences: Abstracts
Ethnic differences in severe asthma clinical care and outcomes: an analysis of United Kingdom primary and specialist care
Busby, J., Heaney, L. G., Brown, T., Chaudhuri, R., Dennison, P., Gore, R., Jackson, D. J., Mansur, A. H., Menzies-Gow, A., Message, S., Niven, R., Patel, M., Price, D., Siddiqui, S., Stone, R. A., Pfeffer, P. E., UK Severe Asthma Registry
The Journal of Allergy and Clinical Immunology: In Practice, vol. 10, no. 2, pp. 495-505
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to move forward
Martinez, F. J., Agusti, A., Celli, B. R., Han, M. K., Allinson, J., Bhatt, S. P., Calverley, P., Chotirmall, S. H., Chowdhury, B., Darken, P., Da Silva, C. A., Donaldson, G., Dorinsky, P., Dransfield, M., Faner, R., Halpin, D. M., Jones, P., Krishnan, J. A., Locantore, N., Martinez, F. D., Müllerová, H., Price, D., Rabe, K. F., Reisner, C., Singh, D., Vestbo, J., Vogelmeier, C. F., Wise, R. A., Tal-Singer, R., Wedzicha, J. A.
American Journal of Respiratory and Critical Care Medicine, vol. 205, no. 3, pp. 275-287